与ALS相关的突变对hSOD1的生物化学和生物物理特征以及聚合形成的影响
Saeede Mohammadi1, Bagher Seyedalipour2, Seyedeh Zohreh Hashemi1
1Department of Molecular and Cell Biology, Faculty of Basic Science, University of Mazandaran, Babolsar, Iran.
Biochemical genetics
|January 10, 2024
概括
突变的人类超氧化物失突酶 (hSOD1) 与肌缩性侧面硬化症 (ALS) 相关的形式更容易聚合. 这些SOD1突变破坏了蛋白质结构的稳定,促进了ALS病理学的中心有毒粉样蛋白形成.
科学领域:
- 生物化学 生化学
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种运动神经元疾病.
- 人类超氧化物失突酶 (hSOD1) 基因的突变与ALS有关.
- 突变hSOD1的毒性机制尚未完全理解.
研究的目的:
- 为了研究两个hSOD1突变体的生物化学特性和粉样蛋白形成.
- 了解特定的氨酸突变对hSOD1结构和聚合的影响.
主要方法:
- 突变hSOD1影响的计算预测.
- 酶活性测定. 酶活性测定.
- 循环二极化 (CD) 谱极性测量.
- 光光谱学 (内在和ANS).
- 使用硫黄素T和刚果红色的粉样纤维化试验.
主要成果:
- 与野生类型相比,hSOD1突变体的特异活性降低.
- 突变者表现出改变的二次结构,增加了疏水性补丁暴露,结构紧性降低.
- 突变物比野生类型的hSOD1.1更快地形成粉样聚合物,并且具有更高的硫黄素T光度.
结论:
- 研究的hSOD1突变体是不稳定的,容易聚集.
- 蛋白质聚合和粉样蛋白形成是与SOD1突变相关的ALS病理学的关键特征.
相关概念视频
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
Multiple Allele Traits
34.2K
The Concept of Multiple Allelism
34.2K


